SBI Securities’s Purple Biotech PPBT Stock Holding History

SBI Securities’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5	Sell	3 -28	-90%	-$94	﹤0.01%	3987
2026 Q1	$125	Sell	31 -1	-3%	-$5	﹤0.01%	3359
2025 Q4	$210	Buy	32 +30	+1,500%	+$218	﹤0.01%	3200
2025 Q3	$11	Hold	2	–	–	﹤0.01%	4025
2025 Q2	$47	Hold	2	–	–	﹤0.01%	3736
2025 Q1	$53	Sell	2 -17	-89%	-$543	﹤0.01%	3629
2024 Q4	$891	Buy	+19	New	+$731	﹤0.01%	2662

SBI Securities's PPBT Position: Q2 2026 in Review

SBI Securities reduced its Purple Biotech (PPBT) stake by 90% in Q2 2026, selling an estimated $94 and leaving 3 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #3987.

SBI Securities first reported a position in PPBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $891 in Q4 2024. 1 fund tracked by Wall St. Rank holds PPBT as of Q2 2026.

SBI Securities held 3 shares of Purple Biotech worth $5 as of Q2 2026.
SBI Securities sold 28 Purple Biotech shares in Q2 2026, an estimated $94.
Purple Biotech made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3987 holding.
SBI Securities first reported a position in Purple Biotech in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Purple Biotech position peaked at $891 in Q4 2024.
1 fund tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.